GlassScriptPhysician profile
Liesl Bredeson
NPI 1093767741
$2,035.80
in general payments reported to CMS, 2019-2025
32 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $209 · 2021: $184 · 2022: $427 · 2023: $459 · 2024: $245 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $258.79 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $238.91 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Organon LLC | $137.77 | 2021-2025 | Nexplanon |
| Gynesonics, INC. | $135.69 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $132.57 | 2021-2025 | Slynd |
| Pfizer INC. | $121.19 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $92.71 | 2021-2023 | |
| Amgen INC. | $92.07 | 2019-2025 | Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $87.18 | 2020-2025 | |
| Millicent US INC | $82.47 | 2022-2025 | Intrarosa, Femring |
| Sumitomo Pharma America, INC. | $65.49 | 2023-2025 | Myfembree |
| Vertical Pharmaceuticals, LLC | $63.06 | 2019-2020 | |
| Shield Therapeutics INC | $61.68 | 2023-2025 | Accrufer |
| Merck Sharp & Dohme LLC | $56.26 | 2019-2024 | Gardasil 9, Gardasil |
| Ascend Therapeutics US, LLC | $44.53 | 2022-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $39.22 | 2019-2020 | |
| Channel Medsystems, INC. | $33.05 | 2023 | |
| Coopersurgical, INC. | $31.34 | 2022-2025 | |
| Innovation Technologies INC | $24.37 | 2023 | Irrisept |
| Agile Therapeutics, INC. | $24.25 | 2021 | |
| Therapeuticsmd, INC. | $23.12 | 2019-2020 | |
| Minerva Surgical, INC | $22.80 | 2022 | |
| Meditrina | $21.49 | 2022 | |
| Integra Lifesciences Corporation | $21.20 | 2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Aspira Women'S Health INC | $20.94 | 2020 | |
| Hologic Sales and Service, LLC | $20.23 | 2025 | Novasure, Omni Hysteroscope, Myosure Tissue Removal Device |
| Siemens Medical Solutions USA, INC. | $17.32 | 2025 | Atellica Ch 930 Analyzer |
| Evofem Biosciences, INC. | $16.24 | 2021 | |
| Lupin INC. | $13.05 | 2019 | |
| Ethicon US, LLC | $12.69 | 2023 | |
| Convatec INC. | $12.18 | 2021 | |
| Duchesnay USA Incorporated | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liesl Bredeson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.